Markus Müschen, MD, PhD, was selected by the Harrington Discovery Institute as a recipient of its 2026 Scholar-Innovator Award. The scholar awards support breakthrough new treatments for common and rare diseases, including cardiovascular, inflammatory, hematologic, and oncologic disease, using small molecule, biologic, cell-based, and genetic therapies. Müschen, Arthur H. and Isabel Bunker Professor of Medicine (Hematology), was selected for his project "Drugging a Key Enzyme to Treat Immune Cell Cancers."
Quick Read